MARIA BLASCO: Open Payments
NPI 1316681695 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 21 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $270 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| Lilly USA, LLC | 4 | $90 |
| Novo Nordisk Inc | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Astellas Pharma US Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $43 |
| CSL Behring | 1 | $33 |
| Amgen Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
Products named: AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, Veozah, Cologuard Collection Kit, Haegarda, KRYSTEXXA, FARXIGA.
Industry payments across MD — which companies pay providers there.
